CA
NZ
UK
AU
IND
US
American Express Company filed a current report on August 5, 2026, announcing the proposed public offering of depositary shares tied to a new series of Fixed Rate Reset Noncumulative Preferred Shares, Series E.
Chipotle Mexican Grill, Inc. filed a Form 8-K on August 5, 2026, disclosing that public health authorities are investigating a salmonella outbreak in the supply chain affecting several food service retailers in Minnesota and other states, and that the company has proactively removed jalapeños …
Webster Financial Corporation filed a Form 8-K on August 5, 2026, disclosing that the Board of Governors of the Federal Reserve System approved Banco Santander's application to acquire the company, with closing expected on August 20, 2026.
BWX Technologies, Inc. filed Amendment No. 1 to its Quarterly Report on Form 10-Q/A for the quarter ended June 30, 2026 on August 5, 2026, solely to furnish inline eXtensible Business Reporting Language (iXBRL) data that was inadvertently omitted from the original filing submitted …
Oaktree Specialty Lending Corporation filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 5, 2026, disclosing financial results for the three and nine months ended June 30, 2026.
Ultragenyx Pharmaceutical Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission, disclosing condensed consolidated financial results and updated risk factors for the second quarter.
Arista Networks, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 5, 2026, reporting results for the three and six months ended June 30, 2026.
Dorian LPG Ltd. filed its Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, reporting on the company's financial and operational status as of that date.
Primoris Services Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the period ended June 30, 2026, disclosing a net loss for both the second quarter and the first half of the year compared with net income …
ACADIA Pharmaceuticals Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing net product sales growth, continued net income, and an expanded balance sheet compared to year-end 2025.
Please wait processing your request...